| Momelotinib (CYT387) |
Influence on cell proliferation |
MTS |
1.00 µM |
DLBCL primary cells |
Canis familriaris |
patient 1 |
|
|
| Momelotinib (CYT387) |
Influence on cell proliferation |
MTS |
2.00 µM |
DLBCL primary cells |
Canis familriaris |
patient 1 |
|
|
| Momelotinib (CYT387) |
Influence on cell proliferation |
MTS |
3.00 µM |
DLBCL primary cells |
Canis familriaris |
patient 1 |
|
|
| Momelotinib (CYT387) |
Influence on cell proliferation |
MTS |
4.00 µM |
DLBCL primary cells |
Canis familriaris |
patient 1 |
|
|
| Momelotinib (CYT387) |
Influence on cell proliferation |
MTS |
5.00 µM |
DLBCL primary cells |
Canis familriaris |
patient 1 |
|
|
